Abstract
Background
Despite state-of-the-art therapeutic strategies for pain, some types of chronic pain remain difficult to treat. We evaluated the effectiveness of an innovative neuromodulative approach to the treatment of chronic pain using electrical stimulus integrated with pharmacological support.
Methods
The MC5-A Calmare© is a new device for patient-specific cutaneous electrostimulation which, by “scrambling” pain information with “no pain” information, aims to reduce the perception of pain intensity. We prospectively treated 73 patients with cancer- (40) and non-cancer-related (33) pain whose pain management was unsatisfactory. The primary objective of the study was to assess efficacy and tolerability of the device. Pain intensity was assessed daily with a Numerical Rating Scale (NRS) for the duration of treatment (2 weeks) and then on a weekly basis for the 2 weeks of follow-up.
Results
Mean pain value at T0 (pre-treatment value) was 6.2 [±2.5 SD (standard deviation)], 1.6 (±2.0) (p < 0.0001) at T2 (after the 10th day of treatment), and 2.9 (±2.6) (p < 0.0001) at T4 (after the second week of follow-up, i.e., 1 month after the beginning of treatment). Response after the second week of treatment showed a clear reduction in pain for both cancer (mean absolute delta of the reduction in NRS value = 4.0) and non-cancer (mean delta = 5.2) patients. The pain score had decreased by 74% at T2. On the basis of pre-established response criteria, there were 78% of responders at T2 and 81% at T4. No side effects were reported.
Conclusions
Our preliminary results suggest that cutaneous electrostimulation with the MC5-A Calmare© can be hypothesized as part of a multimodality approach to the treatment of chronic pain. Further studies on larger numbers of patients are needed to assess its efficacy, to quantify the effects of inter-operator variability, and to compare results obtained from the active device versus those from a sham machine.
Similar content being viewed by others
References
Siddall P, Cousins M (2004) Persistent pain as a disease entity: implications for clinical management. Anesth Analg 99:510–520
Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D (2006) Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain 10:287–333
Breivik H, Cherny N, Collett B, de Conno F, Filbet M, Foubert AJ, Cohen R, Dow L (2009) Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes. Ann Oncol 20:1420–1433
Zenz M, Zenz T, Tryba M, Strumpf M (1995) Severe undertreatment of cancer pain: a 3-year survey of the German situation. J Pain Symptom Manage 10:187–191
Von Roenn J, Cleeland C, Gonin R, Hatfield A, Pandya K (1993) Physician attitudes and practice in cancer pain management. A survey from the Eastern Cooperative Oncology Group. Ann Intern Med 119:121–126
Agency for Health Care Policy and Research (1994) Clinical practice guideline cancer pain management. US Department of Health and Human Services, Rockville
Maltoni M (2008) Opioids, pain, and fear. Ann Oncol 19:5–7
De Leon-Casasola O (2009) Spinal cord and peripheral nerve stimulation techniques for neuropathic pain. J Pain Symptom Manage 38(2S):S28–S38
American Society of Anesthesiologists Task Force on Chronic Pain Management; American Society of Regional Anesthesia and Pain Medicine (2010) Practice guidelines for chronic pain management. Anesthesiology 112:810–833
Smith T, Coyne P, Parker G, Dodson P, Ramakrishnan (2010) Pilot trial of a patient-specific cutaneous electrostimulation device (MC5-A Calmare®) for chemotherapy-induced peripheral neuropathy. J Pain Symptom Manage 40(6):883–891
Foletti A, Durrer A, Buchser E (2007) Neurostimulation technology for the treatment of chronic pain: a focus on spinal cord stimulation. Expert Rev Med Devices 4:201–214
Ghoname E, Craig W, White P, Ahmed HE, Hamza MA, Henderson BN, Gajraj NM, Huber PJ, Gatchel RJ (1999) Percutaneous electrical nerve stimulation for low back pain: a randomized crossover study. JAMA 281:818–823
Harke H, Gretenkort P, Ledleif H, Rahman S (2005) Spinal cord stimulation in sympathetically maintained complex regional pain syndrome type I with severe disability. A prospective clinical trial. Eur J Pain 9:363–373
Mailis-Gagnon A, Furlan A, Sandoval J, Taylor R (2003) Spinal cord stimulation for chronic pain. Cochrane Database Syst Rev 3:CD003783
Khadikar A, Milne S, Brosseau L, Robinson V, Saginur M, Shea B, Tugwell P, Wells G (2005) Transcutaneous electrical nerve stimulation (TENS) for chronic low-back pain. Cochrane Database Syst Rev 4:CD003008
Robb K, Oxberry S, Bennett M, Johnson MI, Simpson KH, Searle RD (2009) A Cochrane systematic review of transcutaneous electrical nerve stimulation for cancer pain. J Pain Symptom Manage 37:746–753
Nnoaham K, Kumbang J (2008) Transcutaneous electrical nerve stimulation (TENS) for chronic pain. Cochrane Database Syst Rev 3:CD003222
Marineo G (2003) Untreatable pain resulting from abdominal cancer: new hope from biophysics? JOP 4:1–10
Sabato AF, Marineo G, Gatti A (2005) Scrambler therapy. Minerva Anestesiol 71:479–482
Gatti A, Sabato AF, Marineo G (2007) Scrambler therapy in neuropathic pain. Pathos 14:99–105
Caraceni A, Cherny N, Fainsinger R, Kaasa S, Poulain P, Radbruch L, De Conno F (2002) Pain measurement tools and methods in clinical research in palliative care: recommendations of an expert working group of European Association of Palliative Care. J Pain Symptom Manage 23:239–255
De Conno F, Caraceni A, Gamba A, Mariani L, Abbattista A, Brunelli C, La Mura A, Ventafridda V (1994) Pain measurements in cancer patients: a comparison of six methods. Pain 57:161–166
Caraceni A, Mendoza TR, Mencaglia E, Baratella C, Edwards K, Forjaz MJ, Martini C, Serlin RC, de Conno F, Cleeland CS (1996) A validation study of an Italian version of the Brief Pain Inventory (Breve Questionario per la Valutazione del Dolore). Pain 65:87–92
Serlin RC, Mendoza TR, Nakamura Y, Edwards KR, Cleeland CS (1995) When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain 61:277–284
Bridges D, Thompson SW, Rice AS (2001) Mechanism of neuropathic pain. Br J Anaesth 87:12–26
Mercadante S (2006) Pathophysiology of chronic pain. In: Bruera E, Higginson IJ, Ripamonti C, von Gunten C (eds) Textbook of palliative medicine. Hodder Arnold, London, pp 359–366
Ricci M, Pirotti S, Burgio M, Scarpi E, Sansoni E, Ridolfi R, Amadori D, Maltoni M (2010) Safety and efficacy of scrambler therapy for cancer pain. J Clin Oncol 28 (suppl; abstr e19591)
Acknowledgment
The authors wish to thank Gráinne Tierney for editing the manuscript.
Conflict of interest
There are no conflicts of interest to declare.
Author information
Authors and Affiliations
Corresponding author
Additional information
This study was partially funded by Legacoop Provincia Forlì-Cesena.
An erratum to this article can be found online at http://dx.doi.org/10.1007/s00520-012-1695-1.
Rights and permissions
About this article
Cite this article
Ricci, M., Pirotti, S., Scarpi, E. et al. Managing chronic pain: results from an open-label study using MC5-A Calmare® device. Support Care Cancer 20, 405–412 (2012). https://doi.org/10.1007/s00520-011-1128-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-011-1128-6